Literature DB >> 34097524

Decline In New Starts Of Psychotropic Medications During The COVID-19 Pandemic.

Ian Nason1, Dorit T Stein2, Richard G Frank3, Murray B Stein4.   

Abstract

COVID-19 interrupted delivery of mental health care in the US. During the initial course of the COVID-19 pandemic new starts of antidepressants declined by 7.5 percent, anxiolytics by 5.6 percent, and antipsychotics by 2.6 percent compared with expected levels. Our findings suggest that there is large unmet need for mental health treatment in the US due to COVID-19.

Entities:  

Year:  2021        PMID： 34097524     DOI： 10.1377/hlthaff.2021.00028

Source DB:  PubMed          Journal:  Health Aff (Millwood)        ISSN： 0278-2715            Impact factor:   6.301


  4 in total

1.  Trends In Outpatient Mental Health Services Use Before And During The COVID-19 Pandemic.

Authors:  Jane M Zhu; Renae Myers; K John McConnell; Ximena Levander; Sunny C Lin
Journal:  Health Aff (Millwood)       Date:  2022-04       Impact factor: 9.048

2.  The effects of COVID-19 on the dispensing rates of antidepressants and benzodiazepines in Canada.

Authors:  Sunjeev Uthayakumar; Mina Tadrous; Simone N Vigod; Sophie A Kitchen; Tara Gomes
Journal:  Depress Anxiety       Date:  2021-11-29       Impact factor: 8.128

3.  New prescription fills of selective serotonin reuptake inhibitors before and during the COVID-19 pandemic in Los Angeles County, California.

Authors:  Jonathan S Levin; Joie Acosta; Laura J Faherty
Journal:  J Affect Disord       Date:  2022-08-31       Impact factor: 6.533

4.  Trends in postpartum mental health care before and during COVID-19.

Authors:  Slawa Rokicki; Maria W Steenland; Caroline K Geiger; Rebecca A Gourevitch; Lucy Chen; Michelle W Martin; Jessica L Cohen
Journal:  Health Serv Res       Date:  2022-08-19       Impact factor: 3.734
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.